Takeda Pharmaceutical Company Limited (NYSE: TAK) reported FY2023 EPS of JPY484.00. Revenue for the year came in at JPY4263.8 billion.

GUIDANCE:

Takeda Pharmaceutical Company Limited sees FY2024 EPS of JPY431.00. Takeda Pharmaceutical Company Limited sees FY2024 revenue of JPY4350 billion.

For earnings history and earnings-related data on Takeda Pharmaceutical Company Limited (TAK) click here.